Glycoprotein-associated amino acid exchangers: Broadening the range of transport specificity

Pflugers Archiv European Journal of Physiology

Volumn 440, Issue 4, 2000, Pages 503-512

  Verrey, François ^a   Meier, Christian ^a   Rossier, Grégoire ^b   Kühn, Lukas C ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

Amino acid transport; Cystinuria; Lysinuric protein intolerance; Membrane carrier; Permease; Proximal kidney tubule; Solute transporter

Indexed keywords

CARRIER PROTEIN; GLYCOPROTEIN;

ACTIVE TRANSPORT; AMINO ACID TRANSPORT; ANIMAL CELL; BRUSH BORDER; CELL PROLIFERATION; COMPLEMENT ACTIVATION; CYSTINURIA; DISULFIDE BOND; ENZYME SPECIFICITY; KIDNEY PROXIMAL TUBULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTOLERANCE; PROTEIN QUATERNARY STRUCTURE; REVIEW; XENOPUS;

AMINO ACID TRANSPORT SYSTEMS; AMINO ACIDS; ANTIGENS, CD; ANTIGENS, CD98; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELL DIVISION; CELL MEMBRANE; EPITHELIUM; GLYCOPROTEINS; HUMANS;

EID: 0033929354     PISSN: 00316768     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004240050001     Document Type: Review

References (57)

1. 1. Azzarone B, Suarez H, Mingari MC, Moretta L, Fauci AS (1984) 4F2 monoclonal antibody recognizes a surface antigen on spread human fibroblasts of embryonic but not of adult origin. J Cell Biol 98:1133-1137
2. 2. Bertran J, Werner A, Moore ML, Stange G, Markovich D, Biber J, Testar X, Zorzano A, Palacin M, Murer H (1992) Expression cloning of a cDNA from rabbit kidney cortex that induces a single transport system for cystine and dibasic and neutral amino acids. Proc Natl Acad Sci USA 89:5601-5605
3. 3. Borsani G, Bassi MT, Sperandeo MP, De Grandi A, Buoninconti A, Riboni M, Manzoni M, Incerti B, Pepe A, Andria G, Ballabio A, Sebastio G (1999) SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance. Nature Genet 21:297-301
4. 4. Bron C, Rousseaux M, Spiazzi AL, MacDonald HR (1986) Structural homology between the human 4F2 antigen and a murine cell surface glycoprotein associated with lymphocyte activation. J Immunol 137:397-399
5. 5. Calonge MJ, Gasparini P, Chillaron J, Chillon M, Gallucci M, Rousaud F, Zelante L, Testar X, Dallapiccola B, Di Silverio F et al. (1994) Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine. Nature Genet 6:420-425
6. 6. Campbell WA, Sah DE, Medina MM, Albina JE, Coleman WB, Thompson NL (2000) TA1/LAT-1/CD98 light chain and system L activity, but not 4F2/CD98 heavy chain, respond to arginine availability in rat hepatic cells: loss of response in tumor cells. J Biol Chem (in press)
7. 7. Chairoungdua A, Segawa H, Kim JY, Miyamoto K, Haga H, Fukui Y, Mizoguchi K, Ito H, Takeda E, Endou H, Kanai Y (1999) Identification of an amino acid transporter associated with the cystinuria-related type II membrane glycoprotein. J Biol Chem 274:28845-28848
8. 8. Christensen HN (1973) On the meaning of effects of substrate structure on biological transport. J Bioenerg 4:31-61
9. 9. Christensen HN (1990) Role of amino acid transport and countertransport in nutrition and metabolism. Physiol Rev 70:43-77
10. 10. Christensen HN, Albritton LM, Kakuda DK, MacLeod CL (1994) Gene-product designations for amino acid transporters. J Exp Biol 196:51-57
11. 0,+AT) of rBAT. Nature Genet 23:52-57
12. 12. Cotner T, Williams JM, Christenson L, Shapiro HM, Strom TB, Strominger J (1983) Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content. J Exp Med 157:461-472
13. 13. Deora A, Ghosh R, Tate S (1998) Progressive C-terminal deletions of the renal cystine transporter, NBAT, reveal a novel bimodal pattern of functional expression. J Biol Chem 273: 32980-32987
14. +L) in human erythrocytes that recognizes lysine and leucine with high affinity. J Physiol (Lond) 454: 491-501
15. 15. Esteban F, Ruiz-Cabello F, Concha A, Perez Ayala M, Delgado M, Garrido F (1990) Relationship of 4F2 antigen with local growth and metastatic potential of squamous cell carcinoma of the larynx. Cancer 66:1493-1498
16. 16. Fenczik CA, Sethi T, Ramos JW, Hughes PE, Ginsberg MH (1997) Complementation of dominant suppression implicates CD98 in integrin activation. Nature 390:81-85
17. 17. Furriols M, Chillaron J, Mora C, Castello A, Bertran J, Camps M, Testar X, Vilaro S, Zorzano A, Palacin M (1993) rBat, related to L-cystine transport, is localized to the microvilli of proximal straight tubules, and its expression is regulated in kidney by development. J Biol Chem 268:27060-27068
18. 18.Gaugitsch HW, Prieschl EE, Kalthoff F, Huber NE, Baumruker T (1992) A novel transiently expressed, integral membrane protein linked to cell activation. J Biol Chem 267: 11267-11273
19. 19. Hara K, Kudoh H, Enomoto T, Hashimoto Y, Masuko T (1999) Malignant transformation of NIH3T3 cells by overexpression of early lymphocyte activation antigen CD98. Biochem Biophys Res Commun 262:720-725
20. 20. Haynes BF, Hemler ME, Mann DL, Eisenbarth GS, Shelhamer J, Mostowski HS, Thomas CA, Strominger JL, Fauci AS (1981) Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J Immunol 126:1409-1414
21. 21. Hediger MA, Rhoads DB (1994) Molecular physiology of sodium-glucose cotransporters. Physiol Rev 74:993-1026
22. 22. Hemler ME, Strominger JL (1982) Characterization of antigen recognized by the monoclonal antibody (4F2): different molecular forms on human T and B lymphoblastoid cell lines. J Immunol 129:623-628
23. 23. Holte H, de Lange Davies C, Beiske K, Stokke T, Marton PF, Smeland EB, Hoie J, Kvaloy S (1989) Ki67 and 4F2 antigen expression as well as DNA synthesis predict survival at relapse/tumour progression in low-grade B-cell lymphoma. Int J Cancer 44:975-80
24. 24. Jaisser F, Jaunin P, Geering K, Rossier BC, Horisberger JD (1994) Modulation of the Na,K-pump function by beta subunit isoforms. J Gen Physiol 103:605-623
25. 25. Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H (1998) Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 273:23629-23632
26. 26. Kanai Y, Stelzner MG, Lee WS, Wells RG, Brown D, Hediger MA (1992) Expression of mRNA (D2) encoding a protein involved in amino acid transport in S3 proximal tubule. Am J Physiol 263:F1087-F1092
27. 27. Karpinski BA, Yang LH, Cacheris P, Morle GD, Leiden JM (1989) The first intron of the 4F2 heavy-chain gene contains a transcriptional enhancer element that binds multiple nuclear proteins. Mol Cell Biol 9:2588-2597
28. 28. Kehrl JH, Muraguchi A, Fauci AS (1984) Differential expression of cell activation markers after stimulation of resting human B lymphocytes. J Immunol 132:2857-2861
29. 29. Lindsten T, June CH, Thompson CB, Leiden JM (1988) Regulation of 4F2 heavy-chain gene expression during normal human T-cell activation can be mediated by multiple distinct molecular mechanisms. Mol Cell Biol 8:3820-3826
30. 30. Lumadue JA, Glick AB, Ruddle FH (1987) Cloning, sequence analysis, and expression of the large subunit of the human lymphocyte activation antigen 4F2. Proc Natl Acad Sci USA 84:9204-9208
31. 31. Luscher B, Rousseaux M, Lees R, MacDonald HR, Bron C (1985) Cell surface glycoproteins involved in the stimulation of interleukin 1-dependent interleukin 2 production by a subline of EL4 thymoma cells. II. Structure, biosynthesis, and maturation. J Immunol 135:3951-3957
32. 32. Mastroberardino L, Spindler B, Pfeiffer R, Skelly PJ, Loffing J, Shoemaker CB, Verrey F (1998) Amino acid transport by heterodimers of 4F2hc/CD98 and members of a permease family. Nature 395:288-291
33. +-independent neutral and basic amino acid transporter on amino acid transport in Xenopus oocytes. J Biol Chem 271:16758-16763
34. 34. Nagase T, Seki N, Ishikawa K, Ohira M, Kawarabayasi Y, Ohara O, Tanaka A, Kotani H, Miyajima N, Nomura N (1996) Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line KG-1 and brain. DNA Res 3:321-329, 341-354
35. 35. Nakamura E, Sato M, Yang H, Miyagawa F, Harasaki M, Tomita K, Matsuoka S, Noma A, Iwai K, Minato N (1999) 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. J Biol Chem 274:3009-3016
36. 36. Palacin M, Estevez R, Bertran J, Zorzano A (1998) Molecular biology of mammalian plasma membrane amino acid transporters. Physiol Rev 78:969-1054
37. 37. Parmacek MS, Karpinski BA, Gottesdiener KM, Thompson CB, Leiden JM (1989) Structure, expression and regulation of the murine 4F2 heavy chain. Nucleic Acids Res 17:1915-1931
38. 38. Pfeiffer R, Loffing J, Rossier G, Bauch C, Meier C, Eggermann T, Loffing-Cueni D, Kuhn LC, Verrey F (1999) Luminal heterodimeric amino acid transporter defective in cystinuria. Mol Biol Cell 10:4135-4147
39. +L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family. EMBO J 18:49-57
40. 40. Pfeiffer R, Spindler B, Loffing J, Skelly P, Shoemaker CB, Verrey F (1998) Functional heterodimeric amino acid transporters lacking cysteine residues involved in disulfide bond. FEBS Lett 439:157-162
41. 41. Pineda M, Fernandez E, Torrents D, Estevez RCL, Camps M, Lloberas J, Zorzano A, Palacin M (1999) Identification of a membrane protein, LAT-2, that co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. J Biol Chem 274:19738-19744
42. 42. Quackenbush E, Clabby M, Gottesdiener KM, Barbosa J, Jones NH, Strominger JL, Speck S, Leiden JM (1987) Molecular cloning of complementary DNAs encoding the heavy chain of the human 4F2 cell-surface antigen: a type II membrane glycoprotein involved in normal and neoplastic cell growth [published erratum appears in Proc Natl Acad Sci USA (1987) 84:8618]. Proc Natl Acad Sci USA 84:6526-6530
43. 0+-like amino acid transporter functioning as a heterodimer with 4F2hc instead of rBAT - a new candidate gene for cystinuria. J Biol Chem 274:29005-29010
44. 44. Rossier G, Meier C, Bauch C, Summa V, Sordat B, Verrey F, Kuhn LC (1999) LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine. J Biol Chem 274:34948-34954
45. 45. Salter DM, Krajewski AS, Sheehan T, Turner G, Cuthbert RJ, McLean A (1989) Prognostic significance of activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma. J Pathol 159:211-220
46. 46. Sato H, Tamba M, Ishii T, Bannai S (1999) Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem 274:11455-11458
47. +-independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem 274:19745-19751
48. 48. Seiser C, Teixeira S, Kuhn LC (1993) Interleukin-2-dependent transcriptional and post-transcriptional regulation of transferrin receptor mRNA. J Biol Chem 268:13074-13080
49. 49. Silbernagl S (1988) The renal handling of amino acids and oligopeptides. Physiol Rev 68:911-1007
50. 2 terminus. J Biol Chem 262: 9574-9580
51. 51. Teixeira S, Kuhn LC (1991) Post-transcriptional regulation of the transferrin receptor and 4F2 antigen heavy chain mRNA during growth activation of spleen cells. Eur J Biochem 202:819-826
52. +L - a candidate gene for lysinuric protein intolerance. J Biol Chem 273:32437-32445
53. +LAT-1, as the lysinuric protein intolerance gene. Nature Genet 21:293-296
54. 54. Verrey F, Jack DL, Paulsen IT, Saier MH, Pfeiffer R (1999) New glycoprotein-associated amino acid transporters. J Membr Biol 172:181-192
55. 55. Wells RG, Hediger MA (1992) Cloning of a rat kidney cDNA that stimulates dibasic and neutral amino acid transport and has sequence similarity to glucosidases. Proc Natl Acad Sci USA 89:5596-5600
56. 56. Wolf DA, Wang S, Panzica MA, Bassily NH, Thompson NL (1996) Expression of a highly conserved oncofetal gene, TA1/E16, in human colon carcinoma and other primary cancers: homology to Schistosoma mansoni amino acid permease and Caenorhabditis elegans gene products. Cancer Res 56: 5012-5022
57. 57. Yagita H, Masuko T, Hashimoto Y (1986) Inhibition of tumor cell growth in vitro by murine monoclonal antibodies that recognize a proliferation-associated cell surface antigen system in rats and humans. Cancer Res 46:1478-1484